This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The 5 Dumbest Things on Wall Street This Week: Sept. 27

Stocks in this article: BBRY AAPL CLDX SEPR AIG FIATY

4. Foolish Filmmaker

Here's a Dumbest tale that has anything but a Hollywood ending.

The Securities and Exchange Commission charged Lawrence Robbins, a moronic Manhattan-based independent filmmaker, with insider trading on a pair of biotech mergers Monday. The SEC alleges Robbins pocketed over $1.5 million in illicit profits after buying options on takeover targets Millennium Pharmaceuticals and Sepracor (SEPR) based on confidential information that he received from his movie business partner John Michael Bennett. The boneheaded Bennett received the tips from his asinine acquaintance Scott Allen who worked at a firm involved with the transactions.

Robbins agreed to settle the SEC's charges by paying more than $1 million. The SEC previously charged Bennett and Allen for their starring roles in the scam.

"Robbins plotted with his business partner to perpetrate an insider trading scheme that enabled him to invest a portion of his illegal profits in their film production company," said Sanjay Wadhwa, Senior Associate Director for Enforcement in the SEC's New York Regional Office. "Their plot, however, did not account for the real world consequences of being caught by the SEC."

Oh man. You just know Sanjay relished that "real world" line. We guarantee he's putting that one in the screenplay he's currently scratching out at home when he's not chasing real life criminals at the office. And you also just know he wants to play himself in the movie.

Come to think of it, Sanjay's future film probably will perform better at the box office than the flops Robbins and Bennett were churning out with the winnings from their illegal option trading. For example, the pair poured money into a 2012 flop called "Playback" which garnered a mere $264 bucks at the box office.

Get with it guys! Don't you know you're supposed to stash insider trading profits in Cayman Island accounts and not Christian Slater vehicles?

Of course, they should also have known that the Feds always investigate highly irregular out-of-the-money call trades in the wake of a big biotech deal. But apparently these foolish filmmakers were not familiar with that well-known Wall Street plot device.

We certainly don't expect the writers hard at work on the big-screen adaptation of "The Stevie Cohen Story" to make that rookie mistake.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs